Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-05
1986-12-02
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546203, A61K 31445
Patent
active
046265422
ABSTRACT:
Pharmaceutical compositions comprising 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds and the use of 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds for treatment of certain cardiovascular disorders are disclosed.
REFERENCES:
patent: 2985660 (1961-05-01), Judd et al.
patent: 3014911 (1961-12-01), Engelhardt
patent: 4022902 (1977-05-01), Remy
patent: 4355036 (1982-10-01), Villani
Fieser et al., Reagents for Organic Synthesis, (1979), pp. 387-388; John Wiley and Sons.
Engelhardt et al., J. Med. Chem., 8, pp. 829-835 (1965).
Merck Index, vol. 10, pp. 398-399 (1983).
Lowe et al., Br. J. Pharmac., 74, pp. 651-663 (1981).
King Stella W.
Remy David C.
Brust Joseph Paul
Merck & Co. , Inc.
Mitri Salvatore C.
Sudol Michael C.
LandOfFree
4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds, pharmac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds, pharmac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds, pharmac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2292832